The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (15.385%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.50
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: Focusrite Revenue Up Over 50% On Acquisitions

Tue, 17th Nov 2020 14:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Focusrite PLC - music and audio products company based in High Wycombe, Buckinghamshire - Pretax profit declines in financial year ended August 31 to GBP7.0 million from GBP13.0 million. While revenue rises to GBP130.1 million from GBP84.7 million thanks to a full year of ADAM Audio revenue and a partial year of Martin Audio, administrative expenses rose to GBP51.5 million from GBP23.0 million and Focusrite incurs a GBP10.2 million impairment of goodwill on acquisition versus no such impairment the prior financial year. CEO Tim Carroll said: "Since the year end, demand for most of our group products has remained high and revenue is substantially ahead of the level achieved in the similar, pre-Covid-19, period of the prior year, helped by the acquisition of Martin Audio. We remain conscious of global factors that could adversely impact our operations such as Covid-19, Brexit, and US tariffs and will continue to monitor these and other obstacles, reacting accordingly."

----------

Windar Photonics PLC- Denmark-based technologies that optimise the energy output of wind turbines - Records pretax loss of EUR1.1 million for six months ended June 30, flat year-on-year. Revenue falls sharply to EUR274,752 from EUR730,597 while administrative expenses fall to EUR1.2 million from EUR1.5 million. CEO Jorgen Jensen said: "Our order intake in 2020 has now reached our net revenue break-even level of [circa] EUR3 million. Whilst we expect to be able to only execute approximately 40% of these orders in 2020 due to the ongoing Covid pandemic, the board still expects to see an improvement in our overall financial results for 2020 compared to last year."

----------

Canadian Overseas Petroleum Ltd - oil and gas exploration and development company focused on offshore Africa - Comprehensive loss for three months ended September 30 is at USD2.2 million, widening from USD936,000 loss the year before due to a USD973,000 stock-based compensation expense relating to stock options granted to directors, officer, and employees. Currently does not have enough cash inflows or financing to develop profitable operations, and is pursuing projects and contracts that need more financing to complete. "The company currently does not have sufficient working capital and cash flows to cover forecasted administrative expenses for next 12 months."

----------

Gear4music Holdings PLC - York-based musical instruments retailer - Swings to GBP5.8 million pretax profit for six months ended September 30 from a GBP279,000 loss the year before as revenue jumps 42% to GBP70.2 million from GBP49.4 million, including 36% invitational revenue growth with UK revenue 48% higher. CEO Andrew Wass said: "Trading into November continues to be very strong, and we are well positioned for what we expect to be a busy peak trading period ahead of us. We therefore expect that results for the financial year will now be ahead of the recently upgraded consensus market expectations."

----------

McKay Securities PLC - real estate investment trust specialising exclusively in the South East and London office, industrial and logistics markets - Swings to GBP15.0 million loss for the six months ended September 30 from a GBP11.2 million the year before. This results from swing to a GBP17.1 million loss on revaluation of investment properties from a GBP3.9 million gain the year before. Gross rents and services charges receivable flat at GBP14.6 million. Interim dividend 2.8 pence per share, in line with year before. CEO Simon Perkins said: "The outlook remains dominated by the speed at which the Covid-19 pandemic passes and the impact it has on the economy. With the achievements of the last six months, and our consistent focus on the UK's strongest regions and sectors, we are in a strong position to navigate this period of uncertainty, and in due course capitalise on future opportunities."

----------

AdEPT Technology Group PLC - information technology provider based in London - Pretax profit in six months ended September 30 sinks sharply to just GBP18,000 from GBP1.1 million the year before as revenue falls to GBP28.5 million from GBP30.8 million and administrative expenses rise to GBP12.7 million from GBP12.4 million. Chair Ian Fishwick said: "We remain reticent to publish guidance for the full year given the ongoing uncertainty. However, we continue to be encouraged by the key indicators of; new order intake, project delivery, cash collection and operational effectiveness which bode well for the remainder of this year."

----------

dotDigital Group PLC - marketing automation and customer engagement software provider based in London - Posts to GBP11.8 million pretax profit in financial year ended June 30, up from GBP8.9 million profit the year before as revenue rises to GBP54.9 million from GBP51.3 million. Proposes final dividend of 0.83 pence per share, up from 0.67p per share the year before. CEO Milan Patel said: "Moving forwards, we remain focused on expanding our international footprint, strengthening our product suite, and deepening our relationships with partners. We will continue to monitor and respond to the pandemic as it develops, but having made a positive start to FY 20/21 and with encouraging momentum in the business, we are confident in our ability to deliver another year of substantial growth and good progress against our strategy."

----------

Genedrive PLC - Manchester-based molecular diagnostics firm - For year ended June 30, pretax loss widens considerably to GP20.4 million from GBP4.5 million loss the year before after incurring GBP14.7 million of finance costs versus just GBP508,000 of finance costs the prior year. Revenue lass than half prior year at GBP1.1 million compared to GBP2.4 million. CEO David Budd said: "With a growing pipeline and opportunities across a range of healthcare markets I believe Genedrive is very well placed for the future. We remain confident in our SARS CoV-2 products and through our network of commercial and other partners we see significant commercial opportunities ahead although additional regulatory clearances are still awaited in certain key territories. We will enter 2021 with a stronger product portfolio and a stronger balance sheet and ready to enter a new growth phase for the company and its assays."

----------

System1 Group PLC - London-based online market research company - Swings to pretax loss of GBP401,000 for six months ended September 30 from a GBP1.1 million profit the year before as revenue falls to GBP10.1 million from GBP13.7 million. No interim dividend, having paid out 1.1p per share the prior year. CEO John Kearon said: "Revenue and adjusted profitability have recovered substantially since Q1. Our sales pipeline remains strong in the UK and is improving in the US. These trends provide grounds for optimism. However, continued uncertainty over the medium- and longer-term impact of Covid-19 on the major economies in which System 1 operates, heightened by renewed 'lock-down' measures, leads us to continue to suspend financial guidance."

----------

Palace Capital PLC - investment company with portfolio of UK commercial real estate located outside of London - Pretax loss widens to GBP7.2 million in six months ended September 30 from GBP1.2 million loss the year before. Rental and other income down 30% at GBP8.3 million from GBP11.9 million plus GBP10.5 million loss on revaluation on investment properties compared to GP6.2 million the previous year. EPRA net tangible assets per share falls 4.7% to 347 pence from 364p. Total dividend per share is reduced to 5.0p from 9.5p per share. CEO Neil Sinclair said: "While the market continues to be relatively uncertain due to the Covid-19 pandemic and with the Brexit deadline also close, we remain confident that the outlook for the UK regions is a positive one; the supply of good quality, well located office assets remains constrained and our portfolio is therefore very well placed, with additional value identified and unlocked as we progress our redevelopment and refurbishment programmes."

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2024 17:26

Genedrive enters clinical trial deal in US for MT-RNR1 US approval

(Alliance News) - Genedrive PLC on Wednesday said it has entered into a clinical trial agreement to support clinical studies to progress the regulatory approval of its MT-RNR1 product.

Read more
3 Apr 2024 16:54

LONDON MARKET CLOSE: FTSE 100 up thanks to US economic data

(Alliance News) - Stock prices in London closed mostly higher on Wednesday, after some data from the US reinforced the interest rate cut trajectory across the Atlantic.

Read more
3 Apr 2024 13:54

Genedrive shares jump on NICE test recommendation

(Sharecast News) - Genedrive shares were surging on Wednesday, after it received a significant endorsement from the UK's National Institute for Health and Care Excellence (NICE) regarding its 'CYP2C19-ID' test.

Read more
3 Apr 2024 11:49

Genedrive shares surge as UK's NICE backs test for ischaemic stroke

(Alliance News) - Genedrive PLC on Wednesday praised the National Health Service's work on strokes and mini strokes as a test by the company received a recommendation from the UK's National Institute for Health & Care Excellence.

Read more
3 Apr 2024 10:47

AIM WINNERS & LOSERS: UK NICE backs Genedrive test; Corero renews deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
28 Mar 2024 14:35

EARNINGS AND TRADING: 888 advances US exit; Arrow ups reserve estimate

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2024 14:27

Genedrive receives R&D tax credit, plans fundraise

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced the receipt of a research and development tax credit totalling £0.8m on Friday, taking its unaudited cash balances to £1.2m.

Read more
15 Mar 2024 13:50

Genedrive down as plans equity raise despite GBP800,000 tax credit

(Alliance News) - Genedrive PLC shares fell on Friday, after it said it has received a GBP800,000 research and development tax credit.

Read more
19 Feb 2024 18:57

TRADING UPDATES: Coro seals sale terms, Powerhouse makes good progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
19 Feb 2024 10:56

Genedrive set to apply for NICE EVA funding

(Sharecast News) - Genedrive shares rose on Monday, on the launch of the NICE early value assessment (EVA) evidence generation funding call, backed by the National Institute for Health and Care Research (NIHR).

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more
2 Jan 2024 14:39

Genedrive confirms £0.6m equity prepayment drawdown

(Sharecast News) - Genedrive confirmed a planned £0.6m drawdown as part of its £5m equity prepayment facility on Tuesday, which it initially disclosed on 31 March 2023.

Read more
2 Jan 2024 10:57

IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility

Genedrive PLC - Manchester, England-based molecular diagnostics company - Draws down GBP600,000 on its GBP5 million equity prepayment facility. In March last year, Genedrive agreed the GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd. At the time it said that proceeds would be used towards the commercialisation of the antibiotic-induced hearing loss test, Genedrive MT-RNR1 ID Kit, and enhancing the Genedrive platform as well as providing additional working capital.

Read more
22 Dec 2023 15:50

UK shareholder meetings calendar - next 7 days

Monday 25 December 
no events scheduled 
Tuesday 26 December 
no events scheduled 
Wednesday 27 December 
Tremor International LtdAGM
Thursday 28 December 
ADVFN PLCAGM
Altona Rare Earths PLCAGM
Beximco Pharmaceuticals LtdAGM
Global Petroleum LtdAGM
Visum Technologies PLCAGM
Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
20 Dec 2023 13:57

Genedrive gets first product orders from several countries

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive has received its first orders for Genedrive MT-RNR1 products from several countries, it announced on Wednesday, including France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.